These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Parkkali T, Käyhty H, Ruutu T, Volin L, Eskola J, Ruutu P. Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852 [Abstract] [Full Text] [Related]
5. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Parkkali T, Käyhty H, Lehtonen H, Ruutu T, Volin L, Eskola J, Ruutu P. Bone Marrow Transplant; 2001 Jan; 27(1):79-84. PubMed ID: 11244441 [Abstract] [Full Text] [Related]
6. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation]. Prager J, Baumert A, Hermann J, Fuchs D, Zintl F. Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263 [Abstract] [Full Text] [Related]
10. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI, Marcus RE. Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630 [Abstract] [Full Text] [Related]
11. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Parkkali T, Käyhty H, Hovi T, Olander RM, Roivainen M, Volin L, Ruutu T, Lahdenkari M, Ruutu P. Bone Marrow Transplant; 2007 Feb; 39(3):179-88. PubMed ID: 17211432 [Abstract] [Full Text] [Related]
12. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Parkkali T, Käyhty H, Anttila M, Ruutu T, Wuorimaa T, Soininen A, Volin L, Ruutu P. Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735 [Abstract] [Full Text] [Related]
13. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group. Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [Abstract] [Full Text] [Related]
14. [Duration of tetanus immunity in relation to the number of doses of vaccine]. Ribero ML, Fara GM, Del Corno G. Boll Ist Sieroter Milan; 1980 Nov 30; 59(5):464-75. PubMed ID: 7248075 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. P N G Med J; 2001 Nov 30; 44(1-2):6-16. PubMed ID: 12418673 [Abstract] [Full Text] [Related]
16. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, Phillips NR, McGarigle C, Harvey S, Schnipper C, Ambrosino DM. Bone Marrow Transplant; 1997 Jul 30; 20(1):33-8. PubMed ID: 9232253 [Abstract] [Full Text] [Related]
17. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults. Southern J, Deane S, Ashton L, Borrow R, Goldblatt D, Andrews N, Balmer P, Morris R, Kroll JS, Miller E. Clin Diagn Lab Immunol; 2004 Nov 30; 11(6):1100-4. PubMed ID: 15539513 [Abstract] [Full Text] [Related]